New Quebec registry tracks hypoglycemia among diabetes patients to help reduce risks

Dr. Rémi Rabasa-Lhoret, a JDRF-funded endocrinologist at the Institut de recherches cliniques de Montréal best known for his work on the artificial pancreas, is overseeing the initiative to collect data for the Quebec-wide registry of people with T1D in order to track the incidence of hypoglycemic episodes and allow patients to better manage their disease.

Exploring oral therapy to safeguard beta cells and treat type 1 diabetes

Administering insulin on a daily basis can be a tedious task, particularly among individuals newly diagnosed with type 1 diabetes (T1D). To mitigate this, researchers are currently experimenting with islet (insulin-producing cells) transplantation as a promising therapy that eliminates the need for insulin injections.

The impact of protein on insulin dosing

Currently, JDRF-funded researcher, Dr. Jan Dutz, and his team at the University of British Columbia are investigating whether the administration of an antibody called ustekinumab among adults and children newly diagnosed with T1D can protect insulin-producing beta cells.

Does pollution cause type 1 diabetes?

As the incidence of type 1 diabetes (T1D) continues to grow, Canadians have long speculated whether environmental factors – namely pollution – could be responsible for triggering an autoimmune attack.

Surviving winter with type 1 diabetes

While the winter season can be a fun time filled with skiing, sledding and mugs of steaming cocoa, it can also be marked by not-so-fun events like the flu, sick days and visits to the clinic.

Stay connected on the latest


Help Us Create a World Without Type 1 Diabetes

Give Now